For decades, the journey from scientific discovery to commercial success has been described as a straight line: make a discovery, publish the results, file a patent, start a company, raise capital, and scale. In reality, this path rarely unfolds in such a clean sequence. Many promising technologies fail not because the science is wrong, but because the process of translation is misunderstood. The Lab-to-Market Transition Model offers a different view. It treats commercialization not as a...

Deep tech is entering a defining decade. What was once considered slow, expensive, and uncertain is now becoming the core of global innovation. The shift is not just about new technologies—it is about a new model of how companies are built, funded, and scaled. At its foundation, deep tech is driven by scientific discovery. Breakthroughs in biotechnology, artificial intelligence, advanced materials, and clean energy are no longer isolated research achievements. They are forming the basis of...

In the era of data-driven healthcare, the fusion of artificial intelligence (AI) and biology is opening up a new frontier in precision medicine. Scientist-entrepreneurs—the bridge between the worlds of research and innovation—are at the forefront of this transformation. By harnessing the power of AI to analyze complex biological data sets, these pioneers are accelerating drug discovery, improving diagnostic accuracy, and personalizing treatment plans in ways never before possible. Precision...